Trial intelligence / Profile preview

Collagenase in Residual Stage Dupuytren's Disease

NCT00014742Phase 3Completed

Sponsor
State University of New York
Modality
Therapeutic Enzymes
01

Overview

Phase 3, randomised, single-blind trial in Dupuytren's contracture comparing Collagenase with Placebo (2 arms). Primary endpoints: Degree of Flexion Deformity at 4 years, Range of Finger Motion at 4 years and 1 more. Status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on NCT00014742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00014742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call